{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:36:40Z","timestamp":1765294600195,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Korea Healthcare Technology Research and Development Project"},{"name":"Ministry for Health, Welfare, and Family Affairs, Republic of Korea","award":["A102065","A085136"],"award-info":[{"award-number":["A102065","A085136"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.clinbiochem.2013.05.048","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T03:03:29Z","timestamp":1369796609000},"page":"1036-1040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis"],"prefix":"10.1016","volume":"46","author":[{"given":"Jinkwon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Jin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hee","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ok-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Suk","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Dae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Mo","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hoe","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1586\/14779072.4.6.801","article-title":"The osteoprotegerin\/RANK\/RANKL system: a bone key to vascular disease","volume":"4","author":"Kiechl","year":"2006","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clinbiochem.2011.12.003","article-title":"Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (trail) levels in malignant and benign pericardial effusions","volume":"45","author":"Karatolios","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0015","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/ATVBAHA.109.199661","article-title":"Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality","volume":"30","author":"Lieb","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0020","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.clinbiochem.2011.04.016","article-title":"Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals","volume":"44","author":"Stepien","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.09.033","article-title":"Osteoprotegerin, vascular calcification and atherosclerosis","volume":"204","author":"Van Campenhout","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0030","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/hr.2011.231","article-title":"Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects","volume":"35","author":"Stepien","year":"2012","journal-title":"Hypertens Res"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000257339","article-title":"Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo","volume":"47","author":"Candido","year":"2010","journal-title":"J Vasc Res"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0040","first-page":"631","article-title":"Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women","volume":"86","author":"Browner","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0045","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.atherosclerosis.2009.03.032","article-title":"Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites","volume":"206","author":"Ali","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0050","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.0000031524.49139.29","article-title":"Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease","volume":"106","author":"Jono","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.amjcard.2006.08.064","article-title":"Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study)","volume":"99","author":"Abedin","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0060","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2796.2009.02163.x","article-title":"Osteoprotegerin concentrations and prognosis in acute ischaemic stroke","volume":"267","author":"Jensen","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199108153250701","article-title":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis","volume":"325","author":"North American Symptomatic Carotid Endarterectomy Trial Collaborators","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000068744","article-title":"Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis","volume":"22","author":"Warfarin\u2013Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators","year":"2003","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0080","first-page":"S1","article-title":"K\/doqi clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0085","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1161\/01.STR.0000089017.90037.7A","article-title":"Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis","volume":"34","author":"Wong","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0090","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0095","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.RES.0000149165.99974.12","article-title":"Regulation of vascular calcification by osteoclast regulatory factors rankl and osteoprotegerin","volume":"95","author":"Collin-Osdoby","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0100","doi-asserted-by":"crossref","first-page":"11201","DOI":"10.1073\/pnas.1932554100","article-title":"Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads","volume":"100","author":"Doherty","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0105","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/ATVBAHA.110.208843","article-title":"Osteoprotegerin: a biomarker with many faces","volume":"30","author":"Caidahl","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0110","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1538-7836.2010.03790.x","article-title":"Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population \u2014 the Tromso study","volume":"8","author":"Vik","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2006.03.002","article-title":"Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans","volume":"191","author":"Vik","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2013.05.048_bb0120","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/01.STR.0000129790.00318.a3","article-title":"Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis","volume":"35","author":"Golledge","year":"2004","journal-title":"Stroke"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013002440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013002440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:42:19Z","timestamp":1757864539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912013002440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0009912013002440"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.05.048","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.05.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}